Re-consent and Continuing Consent

Part of Consent and Vulnerable Populations: Running a Consent Process That Holds.

About 5 minutes. Free, in your language, no account needed.

Why this matters

Consent is not a permission granted once and held thereafter. It is an ongoing state, and it can lapse in substance while remaining intact on paper.

A participant consented to what they were told in a conversation at enrollment. When what they were told stops being true, their consent no longer covers what is happening to them, and nothing in the file changes to show it.

When re-consent is required

New safety information that might affect willingness to continue. This is the most important trigger and the one with the shortest fuse: a participant continuing to receive an intervention whose risk profile has changed, without being told, is continuing on a consent given for a different set of facts.

A protocol change affecting participants: new procedures, a changed schedule, a different duration, an altered risk.

A change in what will be done with data or samples.

A change in the participant's own situation: reaching majority, losing capacity, regaining capacity, becoming pregnant.

A new consent form version approved by the ethics committee, where the change is substantive rather than administrative.

The failure that happens every time

A new consent version is approved and distributed. Sites use it for new participants.

Existing participants continue on the old version, because nobody told the site which existing participants required re-consent and by when.

This is not an occasional error. It is the default outcome unless someone explicitly prevents it, and the reason is structural: the new version arrives as a document, the site files it and starts using it, and using it prospectively is the obvious thing to do with a new form.

The instruction that must accompany every new version is therefore explicit: which existing participants require re-consent, by when, and what happens if a participant cannot be re-consented before their next intervention.

Without those three, sites will do the obvious thing and the obvious thing is wrong.

Re-consent is a conversation

The temptation with a re-consent is to present the new form and obtain a signature, particularly where the change is small.

Where the change is administrative, that may be proportionate. Where it is substantive, and particularly where it concerns safety, it is not: the participant needs to understand what has changed and to decide again in light of it.

The teach-back question adapts directly: what has changed, in your own words, and how do you feel about continuing?

A participant who cannot say what changed has signed a form rather than re-consented.

Withdrawal

Consent's continuing nature includes the right to stop, and that right is frequently weaker in practice than on paper.

It must be easy. A participant who must attend a visit, or have a conversation they find difficult, to withdraw faces a barrier.

It must be free of consequence. Including social consequence. A participant who believes withdrawal will disappoint their physician faces a cost.

It must not require a reason. Asking why is reasonable for the study's own learning and must be plainly optional, and it is frequently asked in a way that feels like being challenged.

Its scope must be clear. Stopping the intervention, stopping visits, and withdrawing data are different, and a participant may want one and not another. A participant who stops the intervention is frequently still willing to be followed up, and that willingness is valuable and must be asked for rather than assumed either way.

In practice

A safety finding requires a consent form update describing a newly identified risk.

The sponsor's communication to sites has three parts rather than one.

The new version, with the change marked.

An explicit instruction: all currently enrolled participants require re-consent before their next dose; participants whose next dose is within seven days should be contacted by telephone and the safety information conveyed before attendance; and no participant may receive further intervention without re-consent.

A tracking template listing every enrolled participant per site with a re-consent status.

Across 40 sites, 312 participants are re-consented within three weeks. Eleven decline to continue, which is the mechanism working: eleven people, given new information about risk, made a different decision.

Without the second and third parts, sites would have used the new form for new participants and the 312 would have continued on a consent that no longer described their situation.

What this looks like when it goes wrong

A protocol amendment adds a procedure and updates the consent form. The ethics committee approves it.

The site receives the new version and uses it for participants enrolled afterwards.

Existing participants undergo the new procedure at their next visit, because the protocol now requires it, and continue on the consent form they signed originally, which does not mention it.

Eighteen participants undergo a procedure they never consented to, over four months, before a monitoring visit identifies it.

Nobody was careless. The site received an approved new consent form and used it, which is what a site does with a new consent form. Nobody told them that eighteen existing participants needed re-consenting before the procedure, and nothing in the document said so.

Key takeaways